Drug Enforcements

Analyze FDA drug enforcement notices, including classifications, firms, and recall scope.

Total records

16,790

Most recent report

September 24, 2025

Last updated

September 30, 2025

Drug Enforcement Records

Sorted by most recent report date.

Back to datasets Page 632 of 672
Recall # Product Firm Status Classification Report date
D-710-2013 Calcium Gluconate 23%, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-784-2013 Tacrolimus (0.02% and 0.03%) drops, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-747-2013 L-ArGiNINE 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-720-2013 Dexpanthenol 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-789-2013 Vitamin 15 (HEMO15) Injection, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-702-2013 Atropine Sulfate 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-794-2013 Voriconazole 5% Ophthalmic drop compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-767-2013 Pento-Gluc 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-783-2013 Stanozolol (50 mg/ml and 100 mg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-742-2013 Idoxuridine 0.1% Injection, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-776-2013 Progesterone 100 mg/ml in Olive Oil Injection, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-772-2013 Phenylephrine 1 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-796-2013 Yohimbine 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-753-2013 Metabolase Forte Injection, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-768-2013 Pentosan 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-765-2013 Papaverine 40 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-716-2013 Deslorelin 15 mg vial, compounded by Olympia Pharmacy, Orlando, FL Lowlite Investments, Inc. D/B/A Olympia Pharmacy Ongoing Class II Jul 17, 2013
D-624-2013 0.9% Sodium Chloride Injection, USP, in MINI-BAG Plus Container, a) 50 mL (NDC 0338-0553-11), b) 100 mL (NDC 0338-0553-18), Rx Only, Baxter, Deerfield, IL 60015 Baxter Healthcare Corp. Terminated Class II Jul 10, 2013
D-629-2013 Metronidazole Injection USP, RTU, 500 mg/100mL in Viaflex Plus Container, Baxter, Deerfield, IL 60015, NDC 0338-1055-48 Baxter Healthcare Corp. Terminated Class II Jul 10, 2013
D-628-2013 Sodium Chloride Injection, USP, a) Product code 2B1301- 50 mL in Viaflex Container Quad Pack (NDC 0338-0049-11); b) 2B1302- 100mL in Viaflex Quad Pack (NDC 0338-0049-18); c) 2B1306- 50 mL in Viaflex Single Pack (NDC 0338-0049-41; d) 2B1307- 100mL in Viaflex Single Pack (NDC 0338-0049-48); e) 2B1308- 50 ML in Viaflex Multi Pack (NDC 0338-0049-31); f) 2B1309- 100mL in Viaflex Multi Pack (NDC 0338-0049-38), Rx Only, Baxter, Deerfield, IL 60015 Baxter Healthcare Corp. Terminated Class II Jul 10, 2013
D-626-2013 Heparin Sodium and 0.9% Sodium Chloride Injection, a) Product code 2B0944, 2000 USP Units, Viaflex Plus Container, 1000mL, (NDC 0338-0433-04), b) Product code 2B0953: 1000 USP Units, Viaflex Plus Container, 500 mL (NDC 0338-0431-03), Baxter, Deerfield, IL 60015 Baxter Healthcare Corp. Terminated Class II Jul 10, 2013
D-625-2013 5% Dextrose Injection, USP, in VIAFLEX Plastic Container Multi Pack, Rx Only, a) 50 mL (NDC 0338-0017-31), b) 100 mL (NDC 0338-0017-38), Baxter, Deerfield, IL 60015 Baxter Healthcare Corp. Terminated Class II Jul 10, 2013
D-639-2013 Estradiol Cypionate 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Clinical Specialties Compounding Pharmacy Terminated Class II Jul 10, 2013
D-671-2013 Test Cyp 25 mg-e(2) blend 12 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Clinical Specialties Compounding Pharmacy Terminated Class II Jul 10, 2013
D-656-2013 Mitomycin 0.04% solution, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 Clinical Specialties Compounding Pharmacy Terminated Class II Jul 10, 2013